Across
- 5. Indicated for patients who have a resting heart rate of at least 70 bpm
- 6. Important lab value to monitor while on furosemide, bumetanide or torsemide
- 7. Increases cardiac output and left ventricular ejection fraction
- 8. Metoprolol, Carvedilol, and ____ are the only 3 beta blockers approved by the FDA for the treatment of heart failure
- 12. Improves heart failure outcomes in patients with or without diabetes
- 14. One of 3 beta blockers FDA-approved to treat heart failure and has alpha-blocking activity
- 17. Electrolyte imbalance that may increase the risk of digoxin toxicity
- 19. A 36-hour washout period is required in patients switching from an ACE inhibitor to _______
- 21. FDA-approved for heart failure in African American patients
Down
- 1. Possible adverse effect of sacubitril/valsartan
- 2. K+ sparing diuretic that has mortality benefit in HFrEF
- 3. Brand name for digoxin
- 4. Relieves fluid retention to decrease preload
- 9. This diabetic medication can cause or exacerbate congestive heart failure
- 10. Generally, patients take diuretics in the _____.
- 11. Also referred to as “diastolic heart failure”
- 13. _________ is an important electrolyte to monitor while on thiazide
- 15. Produced by the ventricular myocardium in response to stretch
- 16. Digoxin-specific antibody used for severe toxicity
- 17. Also referred to as “systolic heart failure”
- 18. Reduces preload, systemic vascular resistance, and myocardial demand
- 20. Most common cause of heart failure